Cargando…

Measured depth of subcutaneous tissue on posterolateral arm of omalizumab patients

Detalles Bibliográficos
Autores principales:	Potts, Ryan, Kim, Laura, Eeuwes, Clark, Dominic, Arunmozhi, Nevis, Immaculate, Kim, Harold L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487821/ http://dx.doi.org/10.1186/1710-1492-8-S1-A5

Ejemplares similares

Measured depth of subcutaneous tissue on posterolateral arm of aeroallergen immunotherapy patients
por: Kim, Laura, et al.
Publicado: (2012)

Patients on subcutaneous allergen immunotherapy are at risk of intramuscular injections
por: Kim, Laura, et al.
Publicado: (2014)

Do epinephrine auto-injectors have an unsuitable needle length for young children?
por: Kim, Laura, et al.
Publicado: (2014)

Value of skin testing children with a family history of food allergy before ingestion of suspect food allergens
por: Dominic, Arunmozhi, et al.
Publicado: (2014)

Auto-injector needle length may be inadequate to deliver epinephrine intramuscularly in women with confirmed food allergy
por: Tsai, Gina, et al.
Publicado: (2014)

Children under 15 kg with food allergy may be at risk of having epinephrine auto-injectors administered into bone
por: Kim, Laura, et al.
Publicado: (2014)

Do epinephrine auto-injectors have an unsuitable needle length in children and adolescents at risk for anaphylaxis from food allergy?
por: Dreborg, Sten, et al.
Publicado: (2016)

Erratum to: Do epinephrine auto-injectors have an unsuitable needle length in children and adolescents at risk for anaphylaxis from food allergy?
por: Dreborg, Sten, et al.
Publicado: (2017)

Effects of omalizumab on chronic urticaria not responding to recommended therapy
por: Hébert, Jacques, et al.
Publicado: (2012)

Efficacy of Omalizumab therapy in a case of severe atopic dermatitis
por: Barrios, Jonathan Lacombe, et al.
Publicado: (2011)

Omalizumab in chronic spontaneous urticaria (CSU): experience in three cases
por: Valle, Solange Oliveira Rodrigues, et al.
Publicado: (2015)

Omalizumab treatment of moderate to severe asthma in the adolescent and pediatric population
por: O’Quinn, John, et al.
Publicado: (2014)

Omalizumab is effective in the treatment of difficult-to-treat chronic spontaneous urticaria
por: Forgie, Jennifer, et al.
Publicado: (2014)

A case report of ABPA, cystic fibrosis and asthma treated with omalizumab
por: Mazza, JA, et al.
Publicado: (2015)

Xolair® (omalizumab) enrollment in a tertiary care allergy and asthma clinic in Canada
por: Cameron, Jodi, et al.
Publicado: (2014)

Administration and burden of subcutaneous immunotherapy for allergic rhinitis in clinical practice in Canada
por: Blume, Steven W, et al.
Publicado: (2014)

Effect of deformation depth on plantar soft tissue behavior
por: Teoh, Jee Chin, et al.
Publicado: (2014)

Follow-up of asthma control and quality of life after discontinuation of omalizumab in severe asthmatic patients
por: Nayci, Sibel, et al.
Publicado: (2015)

Efficacy and safety of the use of omalizumab in a patient with difficult-to-control severe asthma and antiphospholipid antibody syndrome
por: Villela, Rosangela, et al.
Publicado: (2015)

Omalizumab in symptomatic therapy of laryngeal oedema and urticaria attacts in a patient with post operative pulmonary carsinoid tumor
por: Yalcin, Arzu Didem, et al.
Publicado: (2015)

The observed incidence of anaphylaxis and serum sickness in patients receiving omalizumab in a tertiary allergy and asthma clinic in Canada
por: MacRae, Megan, et al.
Publicado: (2014)

Asthma diagnosis and treatment – 1015. Improvements in lung function in an indian population with IgE mediated asthma receiving omalizumab in a real-world setting
por: Guleria, Randeep, et al.
Publicado: (2013)

Health outcomes, education, healthcare delivery and quality – 3038: The relation of sTRAIL levels and quality of life in omalizumab using severe persistent allergic asthma patients
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Use of Omalizumab to treat a nine-year old, with steroid-dependent, allergic asthma, adrenal insufficiency and vertebral compression fractures due to steroid induced severe osteoporosis
por: Ring, Alicia, et al.
Publicado: (2011)

Health outcomes, education, healthcare delivery and quality – 3052. IL-17, IL-18, TGF-beta and GMCSF levels in patients with allergic asthma: Its relation to omalizumab treatment
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Safety of specific subcutaneous immunotherapy in patients with allergic rhinitis
por: Da Fonseca, Mario Henrique Almeida, et al.
Publicado: (2015)

Alpha-linolenic acid supplementation effect in endoplasmic reticulum stress and adiponectin in abdominal subcutaneous adipose tissue in patients with type 2 diabetes mellitus
por: de Holanda Miranda, Wallace Rodrigues, et al.
Publicado: (2015)

Health demographic surveillance in Africa and South Asia – in depth network
por: Hirve, S
Publicado: (2013)

The lateral arm for stereotactic biopsy: how good is it?
por: Denton, E, et al.
Publicado: (2000)

Subcutaneous allergen immunotherapy with dermatophagoides pteronyssinus in patient with local allergic rhinitis
por: Rondon, Carmen, et al.
Publicado: (2015)

The change in Bispectral Index with stimulation indicates depth of sedation in intensive care
por: Dewhurst, AT, et al.
Publicado: (2000)

Depth of Anaesthesia Associated with 2.5% Isoflurane During Cardiopulmonary Bypass
por: Connelly, Michael D, et al.
Publicado: (2015)

Evaluation of algorithms for photon depth of interaction estimation for the TRIMAGE PET component
por: Camarlinghi, Niccolo, et al.
Publicado: (2015)

Depth of Pleural Effusion in Thoracentesis: Comparison of Lateral, Posterolateral and Posterior Approaches in the Supine Position
por: Ko, Jeong Min, et al.
Publicado: (2016)

Evaluation of safety and efficacy of a 20% Subcutaneous Immunoglobulin (Hizentra™), after a dose equivalent switch from intravenous or subcutaneous replacement therapy in a cohort of primary immunodeficient patients
por: Martin, Adriana, et al.
Publicado: (2012)

Prophylactic anticoagulation with low dose enoxaparin: is the subcutaneous route appropriate in the critically ill?
por: Priglinger, U, et al.
Publicado: (2002)

Immunotherapy – 2071. Strail levels decreased after allergen-subcutaneous specific immunotherapy
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Experience with subcutaneous immunoglobulin therapy in two pediatric cases of immune thrombocytopenia purpura
por: Chapdelaine, H, et al.
Publicado: (2012)

Improved quality of life with home therapy with subcutaneous immunoglobulins for patients with secondary hypogammaglobulinaemia
por: Levasseur, Marie-Claude, et al.
Publicado: (2012)

A practical depth-of-interaction PET/MR detector with dichotomous-orthogonal-symmetry decoding
por: Zhang, Yuxuan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_b8datn9kcvamvq1vhl38kgjqrs